MAINZ, Germany, May 27, 2025 -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data from select pipeline candidates across the Company’s diversified oncology ...
- Company to Webcast Investor Event on August 30, 2025, at 1:00 p.m. EDT (7:00 pm CEST)- CAMBRIDGE, Mass., August 11, 2025--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading ...
The Kahneman-Treisman Center announces a new lunchtime seminar series presenting works in progress by Center Affiliates, including the Sugarman Practitioners in Residence. On the third Thursday of ...
Alnylam to Present Progress in Transforming the Treatment of Cardiovascular Disease with RNAi Therapeutics at European Society of Cardiology Congress 2025 - Company to Webcast Investor Event on August ...
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the Company will present new data from its hypertension and transthyretin amyloidosis (ATTR) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback